Brief: LianBio Says Enters Into Agreement Assigning Its Rights For NBTXR3 In China And Other Asian Markets

LianBio

26/12/2023 07:05

Dec 26 (Reuters) - Lianbio  LIAN.O :
    * ENTERS INTO AGREEMENT ASSIGNING ITS RIGHTS FOR NBTXR3 IN
CHINA
AND OTHER ASIAN MARKETS
    * UNDER TERMS OF AGREEMENT, LIANBIO WILL RECEIVE A ONE-TIME
PAYMENT OF $25 MILLION
    * IN ADDITION, LIANBIO IS ELIGIBLE TO RECEIVE A SALES
MILESTONE
PAYMENT OF $5 MILLION
    * FOLLOWING DEAL CLOSE, LIANBIO WILL SUPPORT TRANSITION OF
ASSET
TO JANSSEN FOR A PERIOD NO LONGER THAN SIX MONTHS
    * AGREEMENT WITH JANSSEN WHEREBY LIAN HAS ASSIGNED TO
JANSSEN
LIANBIO'S EXCLUSIVE RIGHTS TO DEVELOP AND COMMERCIALIZE NBTXR3

Source text for Eikon:  ID:nGNX1hlHY0 
Further company coverage:  LIAN.O 

 ((Reuters.Briefs@thomsonreuters.com;))